Results 201 to 210 of about 64,045 (290)

Real-World Outcomes of Intraoperative Intravitreal Triamcinolone at Phacoemulsification Cataract Surgery in Eyes with a History of Diabetic Macular Edema. [PDF]

Clin Ophthalmol
Affoo AS, Bhola R, Badasee V, Luces V, Sookhoo J, Ramnarine C.   +5 more
europepmc   +1 more source

Minocycline and bone marrow–derived mononuclear cells as potential therapeutics for hereditary retinal degenerations

Acta Ophthalmologica, Volume 104, Issue 6, Page e671-e685, September 2026.
Abstract Purpose To assess in Royal College of Surgeons (RCS) rats if the combination of two previously documented neuroprotective strategies: minocycline administration and bone marrow–derived mononuclear cells (BM‐MNCs) intravitreal transplantation, offers enhanced neuroprotection compared with each treatment alone.
Alba Videla‐Ristol, Ana Martínez‐Vacas, David García‐Bernal, Manuel Vidal‐Sanz, María Paz Villegas‐Pérez, Diego García‐Ayuso, Johnny Di Pierdomenico   +6 more
wiley   +1 more source

The impact of systemic long‐term medications for the development of age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 6, Page 674-681, September 2026.
Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä, Reijo Sund, Toni Rikkonen, Kai Kaarniranta   +3 more
wiley   +1 more source

Effects of Intravitreal Anti-VEGF Therapy on Conjunctival Flora and Antibiotic Resistance in Age-Related Macular Degeneration. [PDF]

Microorganisms
Gündüz A, Ekici Gök Z, Evren Ö.
europepmc   +1 more source

Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizuma

Journal of Rawalpindi Medical College, 2016
Background: To study the rate of different complications of intravitreal Bevacizumab while treating patients of different posterior segment diseases. Methods: A prospective study of 60 patients having different retinal diseases like diabetic retinopathy, wet age related macular degeneration (AMD), retinal vein occlusion (RVO),was carried out.
openaire   +1 more source

Association of treated neovascular AMD with disability and mood disorders: A longitudinal nationwide study

Acta Ophthalmologica, Volume 104, Issue 6, Page e648-e654, September 2026.
Abstract Purpose To describe the associations of treated neovascular AMD with the risk of disability, falls, fractures and mood disorders in a large sample representative of the French population. Methods Analyses were based on 77 582 individuals belonging to the ‘Echantillon Généraliste des Bénéficiaires’, a 1/97 random sample of the French population,
Cécile Delcourt, Emilie Hucteau, Sarra Gattoussi, Karine Pérès, Marie‐Noelle Delyfer, Catherine Helmer, Jean‐François Korobelnik   +6 more
wiley   +1 more source

Improvement in visual outcomes in diabetic macular edema through the reduction of macular thickness fluctuations using the 0, 19 mg fluocinolone acetonide implant. [PDF]

Int Ophthalmol
Penas S, Pessoa B, Teixeira C, Ruão M, Sousa JPC, Carneiro Â, Silva R, Meireles A.   +7 more
europepmc   +1 more source

Intravitreal Delivery of Cationic DMP Micelles Suppresses Choroidal Neovascularization

MedComm – Biomaterials and Applications, Volume 5, Issue 3, September 2026.
Yingying Chen, Jieping Wu, Ke Men, Jiamei Yang, Mohan Liu, Meixia Zhang   +5 more
wiley   +1 more source

Determination of Human Effective Dose via Translational Ocular Modeling: Clinical Translation of a Novel Topical Agent Using PBPK

Clinical and Translational Science, Volume 19, Issue 9, September 2026.
Schematic workflow of the translational study. ABSTRACT Wet age‐related macular degeneration (wAMD) is a leading cause of vision loss, and human dose selection for ocular therapeutics remains a key translational challenge. We developed a physiologically based pharmacokinetic (PBPK) model for EB‐203 to guide dose selection by translating preclinical ...
Woojin Jung, Jamie Jaeheung Lee, Yunseok Cho, Kyoung Ah Min, Hwi‐yeol Yun, Soyoung Lee, Jaewook Yang, Jung‐woo Chae   +7 more
wiley   +1 more source

Longitudinal Changes in Ganglion Cell Complex Thickness Before and After Intravitreal Bevacizumab Injections in Diabetic Macular Edema. [PDF]

Diagnostics (Basel)
Jun HW, Hwang DD.
europepmc   +1 more source